Top Markets
Coin of the day
SD BioSensor, Inc SD BioSensor, Inc

SD BioSensor, Inc

137310
Rank in Stocks #13260
SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced... SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.
Share Price
$4.23
Market Cap
$506.22M
Change (1 day)
-2.86%
Change (1 year)
-41.34%
Country
KR
Trade SD BioSensor, Inc (137310)

Category

Number of shares outstanding for SD BioSensor, Inc (137310)
Number of shares outstanding as of August 2026: 0
According to SD BioSensor, Inc latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for SD BioSensor, Inc (137310) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
354.50M -
US
461.20M -
FR
- -
JP
274.79M -
US
- -
CH